Skip to main content

Advertisement

Log in

Radiochemical Synthesis, Rodent Biodistribution and Tumor Uptake, and Dosimetry Calculations of [11C] Methylated LY2181308

  • Research Article
  • Published:
Molecular Imaging and Biology Aims and scope Submit manuscript

Abstract

Purpose

The aim of the study was to develop a rapid and reproducible method to label LY2181308, an antisense oligonucleotide to Survivin, with carbon-11 in order to study its in vivo biodistribution and tumor uptake in rodents and its human dosimetry based on baboon data.

Methods

Randomly [11C] methylated LY2181308 was produced with [11C] methyl iodide. The biodistribution was performed in female Sprague–Dawley (SD) rats and EMT-6 tumor-bearing mice in the presence of nonradioactive LY2181308. Human dosimetry calculations were based on baboon PET studies.

Results

In SD rats, the kidney and liver were the organs with the most accumulation of radioactivity. Tumor uptake in mice was also relatively high after 5 min and remained constant for up to 1 h. Baboon dosimetry suggested that up to 42 mCi of radioactivity could be administered to human with a dose-limiting organ being the kidneys with a radiation dose of 32 µGy/MBq (0.118 rad/mCi).

Conclusions

[11C] Methylated LY2181308 to rodents and baboons showed its biodistribution, tumor uptake, and human dosimetry evaluation. These results should facilitate the understanding of the pharmacokinetics of LY2181308 prior to use as a potential new therapeutic agent in oncology as well as to warrant more in vivo validations as a potentially useful tumor-imaging agent.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Ambrosini G, Adida C, Altieri DC (1997) A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3:917–921

    Article  CAS  PubMed  Google Scholar 

  2. Altieri DC (2001) The molecular basis and potential role of survivin in cancer diagnosis and therapy. Rev Trends Mol Med 7:542–547

    Article  CAS  Google Scholar 

  3. Zaffaroni N, Daidone MG (2002) Survivin expression and resistance to anticancer treatments: perspective for new therapeutic interventions. Drug Resist Updat (review) 5:65–72

    Article  CAS  Google Scholar 

  4. Kallio MJ, Nieminen M, Eriksson JE (2001) Human inhibitor of apoptosis protein (IAP) survivin participates in regulation of chromosome segregation and mitotic exit. FASEB J 15:2721–2723

    CAS  PubMed  Google Scholar 

  5. Li F, Ambrosini G, Chu EY et al (1998) Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396:580–584

    Article  CAS  PubMed  Google Scholar 

  6. Olie RA, Simoes-Wust P, Baumann B et al (2000) A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy. Cancer Res 60:2805–2809

    CAS  PubMed  Google Scholar 

  7. Younes CK, Boisgard R and Tavitian B (2002) Labelled oligonucleotides as radiopharmaceuticals: pitfalls, problems and perspectives. Curr Pharm Des 8:1451–1466

    Article  CAS  PubMed  Google Scholar 

  8. Dolle F, Hinnen F, Vaufrey F et al (1997) A general method for labeling oligodeoxynucleotides with F-18 for in vivo PET imaging. J Labl Comp Radiopharm 39:319–330

    Article  CAS  Google Scholar 

  9. Tavitian B, Terrazzino S, Kuhnast B et al (1998) In vivo imaging of oligonucleotides with positron emission tomography. Nature Med 4:467–471

    Article  CAS  PubMed  Google Scholar 

  10. Dence CS, Sun X, Mach RH, Welch MJ (2005) [11C]-methylated LY2181308, an antisense oligonucleotide to survivin: radiochemical synthesis and preliminary rodent biodistribution studies. J Labl Comp Radiopharm 48:S161

    Google Scholar 

  11. Dence CS, Laforest R, Sharp TL, Mach RH, Welch MJ (2007) [11C]-methylated LY2181308, an antisense oligonucleotide to survivin: part II-human dosimetry calculation. J Labl Comp Radiopharm 50:S449

    Google Scholar 

  12. Saleem A, Ranson M, Callies S, Lahn M, Prenant C, Brown G, Mathews JC, Dence CS, McMahon A, Price P (2009) Microdosing imaging pharmacokinetic (PK) study of the anti-sense oligonucleotide (ASO) to Survivin (LY 2181308) using positron emission tomography (PET): a novel paradigm in clinical drug development. J Clin Oncol 27(No 15S):3578

    Google Scholar 

  13. USP 32-NF 27 (2009) First supplement chapter <467>

  14. Iskandar ZA and Al-Joudi FS (2006) Expression of survivin in fetal and adult normal tissue of rat. Malaysian J Pathol 28:101–106

    CAS  Google Scholar 

  15. Sohn DM, Kim SY, Baek MJ et al (2006) Expression of survivin and clinical correlation in patients with breast cancer. Biomed Pharmacotherapy 60:289–292

    Article  CAS  Google Scholar 

  16. Kennedy SM, O’Driscoll L, Purcell R et al (2003) Prognostic importance of survivin in breast cancer. Br J Cancer 88:1077–1083

    Article  CAS  PubMed  Google Scholar 

  17. Tanaka K, Iwamoto S, Gon G et al (2000) Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin Cancer Res 6:127–134

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We thank Nicole Fettig, Margaret Morris, Paul Eisenbeis, and Mark Nolte for their contributions to the animal studies and Bill Margenau and Dave Ficke for isotope production. We also thank Lynne Jones, Karen Dotson, and Joseph B. Dence for their editorial assistance. This work was supported by Eli Lilly and Co, Indianapolis, IN, USA.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Carmen S. Dence.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dence, C.S., Laforest, R., Sun, X. et al. Radiochemical Synthesis, Rodent Biodistribution and Tumor Uptake, and Dosimetry Calculations of [11C] Methylated LY2181308. Mol Imaging Biol 12, 608–615 (2010). https://doi.org/10.1007/s11307-010-0319-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11307-010-0319-8

Key words

Navigation